NERVGEN PHARMA CORP. Adjustments For Unrealised Foreign Exchange Losses Gains
NERVGEN PHARMA CORP. (NGEN) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -CAD 452.13 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2026-03-31
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2025-12-31 | -452.13K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 294.34K CAD 40-F · filed 2026-03-31 |